
	Mr. Jonathan I. Lieber has been Chief Financial Officer and Senior Vice President of Metamark Genetics, Inc. since January 29, 2014. Mr. Lieber is a Co-Founder and General Partner of Wheatley Partners, L.P. He is Founder and General Partner of Buckland Partners. He specializes in the services, software, and communications sectors. Mr. Lieber has more than a decade of experience as the chief financial officer of emerging life-sciences companies including, Repligen Corporation, Xcellerex (acquired by GE Healthcare), and Altus Pharmaceuticals. He served as Chief Financial Officer and Treasurer of Repligen Corporation since September 21, 2012. He served as the Chief Financial Officer of Xcellerex, Inc. since July 2009. Previously, Mr. Lieber served as a Principal and Vice President at GeoCapital. Prior to this, he worked as an Investment Analyst a Gabelli &amp; Co. and Woodland Venture Fund. He served as Chief Financial Officer, Senior Vice President and Principal Accounting Officer of Altus Pharmaceuticals Inc. until March 27, 2009. He served as Vice President of Finance of Altus Pharmaceuticals Inc. since July 2002 and also as its Treasurer since September 2005. Mr. Lieber is involved in healthcare financings totaling over $3 billion in common stock and over $500 million in initial public offerings. Mr. Lieber sits on the Boards of several Wheatley portfolio companies. He holds an M.B.A. with honors from Columbia Business School and an A.B. from Brown University. He received a B.S. in business administration and finance from Boston University and an M.B.A. in finance from New York University Stern School of Business.
